Published: 2020-03-26

Correlation of coagulation markers with axillary lymph node metastasis in breast malignancy: a tertiary care centre study in North India

Vaibhav Srivastava, Nandan Rai, Shabi Ahmad, Vikram Singh, Shirish Kumar


Background: Breast cancer is the most common female cancer worldwide representing nearly a quarter (25%) of all cancers. Search for a marker which can predict lymph node metastasis in clinically negative axilla has been a matter of research for long. The present study is an attempt to evaluate role of coagulation makers with special reference to D-dimer and factor 7 and 8 in patients of carcinoma breast in predicting lymph node metastasis in carcinoma patients.

Methods: The study was a prospective study conducted in 50 diagnosed patients of carcinoma breast in whom D dimer levels and factor 7 and 8 levels were measured at the time of commencement of the treatment and at six weeks after surgery.

Results: Most of the patients in the study group were in the age group 41-70 (80%) years. 22% patients were of early Breast cancer. The reduction in D-dimer, factor VII and factor VIII value after 6 weeks of surgery were significant (p value 0.0001 for all three).

Conclusions: D-dimer and factor VII were found to be an independent predictive factor for lymph node metastatsis, thus providing as a safe, easy, objective and convenient supplement to sentinel node biopsy in assessing metastatic disease in axilla. Combined- with other biomarkers, it may prove to be an alternative to sentinel node biopsy in assessing metastatic disease in axilla. Significant postoperative decrease in D-dimer, factor VII and factor VIII may provide objective criteria to assess completion of surgery.


D-dimer, Factor 7, Factor 8, Breast malignancy

Full Text:



Porter PL. Global trends in breast cancer incidence and mortality. Salud Pública de México. 2009;51:141-6.

Babu GR, Lakshmi SB, Thiyagarajan JA. Epidemiological correlates of breast cancer in South India. Asian Pac J Cancer Prev. 2013;14:5077-83.

Ali I, Wani WA, Saleem K. Cancer scenario in India with future perspectives. Cancer Therapy. 2011;8:56-70.

Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005;366:1744-9.

Balasubramaniam S, Rotti S, Vivekanandam S. Risk factors of female breast carcinoma:a case control study at Puducherry. Indian J Cancer. 2013;50:65-70.

Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham prognostic index in primary breast cancer. Breast Cancer Research and Treatment. 1992;22(3):207-19.

van Duijnhoven EM, Lustermans FA, van Wersch JW. Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer. Haemostasis.1993;23:168-72.

Beer JH, Haeberli A, Vogt A. Coagulation markers predict survival in cancer patients. Thromb Haemost. 2002;88:745-9.

Khangarota SS, Guptab N, Goswamic B, Hadkea NS, Lala P, Guptad N, et al. Correlation of D dimer and factor VIII levels with histopathology in patients with breast carcinoma. Cancer Biomark. 2010;7:305-14.

Dirix L, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86:389-95.

Yigit E, Gonullu G, Yucel I, Turgut M, Erdem D, Cakar B. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer. Eur J Intern Med. 2008;19:602-7.

Blackwell K, Haroon Z, Broadwater G, Berry D, Harris L, Iglehart JD, et al. Plasma D-Dimer Levels in Operable Breast Cancer Patients Correlate With Clinical Stage and Axillary Lymph Node Status. J Clin Oncol. 2000;18:600-8.

Khan MZ, Khan MS, Raziq F, Khattak AM. Fibrinogen degradation products and d- dimers in patients with breast carcinoma. Gomal J Med Sci. 2007;5(1):9-12.

Choudhary GS, Bairwa MS, Choudhary A, Singodia R. Correlation of coagulation markers with axillary lymph node metastasis in carcinoma breast. J Evol Med Dent Sci. 2017;6(91):6449-53.